<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04253054</url>
  </required_header>
  <id_info>
    <org_study_id>CMCS-Beijing 2020</org_study_id>
    <nct_id>NCT04253054</nct_id>
  </id_info>
  <brief_title>Chinese Multi-provincial Cohort Study-Beijing Project</brief_title>
  <acronym>CMCS</acronym>
  <official_title>Chinese Multi-provincial Cohort Study-Beijing Project</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Institute of Heart, Lung and Blood Vessel Diseases</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Institute of Heart, Lung and Blood Vessel Diseases</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Chinese Multi-provincial Cohort Study (CMCS)-Beijing project is a sub-study in CMCS
      participants from Beijing, which intended to investigate the progression and determinants of
      atherosclerosis and aging related health problems through repeat examinations. Exam 0 to Exam
      3 have been conducted during 1992 to 2012. Exam 4 is scheduled in 2020.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">May 2020</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>All fatal and nonfatal acute coronary and stroke events</measure>
    <time_frame>From date of enrollment until the date of first documented event or date of cardiovascular death, whichever came first, assessed at least 5 years</time_frame>
    <description>Acute coronary heart disease events included acute myocardial infarction, sudden death, and other coronary deaths. Acute stroke events included subarachnoid hemorrhage, intracerebral hemorrhage, or cerebral infarction.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>New-onset of coronary events</measure>
    <time_frame>From date of enrollment until the date of first documented event or date of CHD death, whichever came first, assessed at least 5 years</time_frame>
    <description>Acute coronary heart disease events included acute myocardial infarction, sudden death, and other coronary deaths.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New-onset of stroke</measure>
    <time_frame>From date of enrollment until the date of first documented event or date of stroke death, whichever came first, assessed at least 5 years</time_frame>
    <description>Acute stroke events included subarachnoid hemorrhage, intracerebral hemorrhage, or cerebral infarction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total death</measure>
    <time_frame>From date of enrollment until date of death from all cause, assessed at least 5 years</time_frame>
    <description>All cause death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive dysfunction</measure>
    <time_frame>From date of enrollment until date of first documented event, assessed at least 5 years</time_frame>
    <description>Cognitive dysfunction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Olfactory Disorders</measure>
    <time_frame>From date of enrollment until date of first documented event, assessed at least 5 years</time_frame>
    <description>Olfactory Disorders</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Valvular disease</measure>
    <time_frame>From date of enrollment until the date of first documented event or date of valvular disease death, whichever came first, assessed at least 5 years</time_frame>
    <description>Valvular disease</description>
  </secondary_outcome>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <condition>Cardiovascular Risk Factor</condition>
  <condition>Aging Problems</condition>
  <condition>Smell Disorder</condition>
  <condition>Sleep</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cardiovascular risk factors</intervention_name>
    <description>Different level of cardiovascular risk factors, such as aging, hypertension, diabetes, dyslipidemia, smoke, alcohol drink, obesity and et al, associated with genetics, environments and lifestyles</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Aging related health problems</intervention_name>
    <description>Aging related health problems</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum, plasma, blood cell and urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Study participants were recruited from the Chinese Multi-provincial Cohort Study-Beijing
        Project
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants from CMCS-Beijing

          -  sign the informed consent

        Exclusion Criteria:

          -  participanting in clinical trials
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jing Liu, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beijing Sijiqing Hospital, Beijing</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peking University Hospital, Beijing</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peking University Shougang Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>January 22, 2020</study_first_submitted>
  <study_first_submitted_qc>January 31, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2020</study_first_posted>
  <last_update_submitted>April 9, 2020</last_update_submitted>
  <last_update_submitted_qc>April 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Olfaction Disorders</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

